KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Total Debt (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Total Debt readings, the most recent being $16.6 billion for Q1 2026.

  • On a quarterly basis, Total Debt changed 0.14% to $16.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $16.6 billion, a 0.14% change, with the full-year FY2025 number at $16.8 billion, down 5.49% from a year prior.
  • Total Debt hit $16.6 billion in Q1 2026 for Teva Pharmaceutical Industries, down from $16.8 billion in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $22.9 billion in Q1 2022 to a low of $16.6 billion in Q1 2026.
  • Median Total Debt over the past 5 years was $19.6 billion (2024), compared with a mean of $19.3 billion.
  • Biggest five-year swings in Total Debt: dropped 15.24% in 2025 and later dropped 0.14% in 2026.
  • Teva Pharmaceutical Industries' Total Debt stood at $21.2 billion in 2022, then decreased by 6.5% to $19.8 billion in 2023, then decreased by 10.34% to $17.8 billion in 2024, then decreased by 5.49% to $16.8 billion in 2025, then decreased by 1.07% to $16.6 billion in 2026.
  • The last three reported values for Total Debt were $16.6 billion (Q1 2026), $16.8 billion (Q4 2025), and $16.8 billion (Q3 2025) per Business Quant data.